Loratadine
Loratan contains loratadine, an antiallergic medicine that does not cause drowsiness.
During an allergic reaction, various substances (so-called mediators) are released, causing the development of allergy symptoms. One of the most important mediators is histamine. Loratan, as an antihistamine, inhibits the activity of histamine, thus showing an antiallergic effect. Loratan relieves symptoms caused by histamine during an allergic reaction: itching, redness, swelling, and nasal discharge.
The medicine is indicated for the treatment of symptoms of allergic rhinitis (such as sneezing, runny nose, nasal itching, palate itching, eye itching and burning, and tearing) and chronic idiopathic urticaria (such as skin itching and redness with typical skin changes).
Tell your doctor or pharmacist about all medicines you are taking, or have recently taken, and about any medicines you plan to take.
Taking loratadine with ketoconazole (used for fungal infections), erythromycin (used for bacterial infections), or cimetidine (used for stomach ulcers) may increase the level of loratadine in the blood, but without significant clinical changes (including changes in the electrocardiogram - EKG).
No significant interactions between loratadine and other medicines are known.
Taking the medicine with food may slightly delay the absorption of loratadine, but it does not affect its action.
The medicine can be taken with or without food.
Loratadine taken with alcohol does not enhance its effects to a degree that can be measured in psychomotor tests.
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Due to the lack of sufficient data on the safety of use, Loratan should not be used during pregnancy.
Loratadine passes into breast milk, so it is not recommended to take Loratan during breastfeeding.
In some people, drowsiness may occur, which may affect the ability to drive and use machines.
The medicine may cause allergic reactions.
Always take this medicine exactly as your doctor has told you. If you are not sure, ask your doctor or pharmacist.
Take the medicine by mouth. Swallow the capsule whole.
Loratan can be taken with or without food.
The usual dose is:
Adults and children over 6 years of age with a body weight over 30 kg - 1 capsule (10 mg) once daily.
It is not recommended to use Loratan in the form of a capsule (10 mg) in children with a body weight less than 30 kg.
In patients with severe liver impairment, a lower initial dose should be used, as the clearance of loratadine may be reduced in these patients. In such cases, 10 mg of loratadine (1 capsule) should be taken every other day.
No dose adjustment is needed in elderly patients and patients with renal impairment.
If you take more than the recommended dose, contact your doctor or pharmacist immediately.
The main symptoms of overdose are: drowsiness, rapid heartbeat, and headache.
In case of overdose, symptomatic and supportive treatment should be applied immediately and continued as long as necessary. Activated charcoal can be given as a water suspension. The doctor may perform gastric lavage. Loratadine cannot be eliminated from the body by hemodialysis. It is not known whether it can be eliminated by peritoneal dialysis. After completing intensive treatment, further observation of the patient is necessary.
Do not take a double dose to make up for a forgotten dose.
If you have any further questions about taking this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Common side effects(affecting 1 to 10 people in 100):
Uncommon side effects(affecting 1 to 10 people in 1000):
Rare side effects(affecting less than 1 person in 10,000):
Side effects of unknown frequency(frequency cannot be estimated from available data):
If you experience any side effects, including any not listed in this leaflet, please tell your doctor or pharmacist. Side effects can be reported directly to the Department of Drug Safety Monitoring of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products:
Al. Jerozolimskie 181C, 02-222 Warsaw
tel.: +48 22 49 21 301, fax: +48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
Reporting side effects will help to gather more information on the safety of this medicine.
Store in the original package, at a temperature below 25°C.
Keep the medicine out of the sight and reach of children.
Do not use this medicine after the expiry date stated on the package. The expiry date refers to the last day of the month.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Soft capsules, oval, dark blue, with a smooth, shiny surface.
One pack of the medicine contains 15 or 30 capsules.
“PRZEDSIĘBIORSTWO PRODUKCJI FARMACEUTYCZNEJ HASCO-LEK” S.A.
51-131 Wrocław, ul. Żmigrodzka 242 E
tel.: 22 742 00 22
e-mail: informacjaoleku@hasco-lek.pl
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.